ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors

Zhang, Rui; Zeng, Ying; Deng, Jun-Li*南方医科大学
CLINICAL AND EXPERIMENTAL MEDICINE2023-9DOI: 10.1007/s10238-022-00947-5
2被引7阅读
引用收藏
分享

摘要

Long non-coding RNAs play important roles in cellular functions and disease development. H19, as a long non-coding RNA, is pervasively over-expressed in almost all kinds of human malignant tumors. Although many studies have reported that H19 is closely associated with tumor cell proliferation, apoptosis, invasion, metastasis, and chemoresistance, the role and mechanism of H19 in gene regulation and tumor development are largely unclear. In this review, we summarized the recent progress in the study of the major functions and mechanisms of H19 lncRNA in cancer development and progression. H19 possesses both oncogenic and tumor-suppressing activities, presumably through regulating target gene transcription, mRNA stability and splicing, and competitive inhibition of endogenous RNA degradation. Studies indicate that H19 may involve in cell proliferation and apoptosis, tumor initiation, migration, invasion, metastasis and chemoresistance and may serve as a potential biomarker for early diagnosis, prognosis, and novel molecular target for cancer therapy.

学科与关键词

关键词
LncRNAH19MetastasisEMTChemoresistanceTumors
相关
加载中…
  • Long non-coding RNA: a new player in cancer
    Zhang Hua; Chen Zhenhua; Wang Xinxin; Huang Zunnan; He Zhiwei*; Chen YueqinJournal of Hematology and Oncology, 2013, 6: 37.被引 58
  • The regulatory mechanisms of long noncoding RNAs and their role in cancer
    Bin YAN; YiQun JIANG; Ya CAO; YongGuang TAOChinese Science Bulletin (Chinese Version), 2012, 57(36): 3467.
  • H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications
    Zhu, Leiqi; Li, Yuanyang; Xia, Fangqi; Xue, Mengzhen; Wang, Yaqi; Jia, Dengke; Gao, Yan; Li, Luoying; Shi, Yue; Chen, Silong; Xu, Guangfu; Yuan, Chengfu*Current Pharmaceutical Design, 2022, 28(12): 1011-1018.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
CLINICAL AND EXPERIMENTAL MEDICINE
发表日期
2023-09
卷期
第 23 卷, 第 5 期
页码
1425-1440
DOI
10.1007/s10238-022-00947-5
语言
ENGLISH
成果收录
SCIE
资助标注
Traditional Chinese Medicine Bureau of Guangdong Province [20221282]; National Natural Science Foundation of China [82003870]; Natural Science Foundation of Changsha [kq2014012]

作者

  • Z

    Zhang, Rui (第一作者)

    2

  • Z

    Zeng, Ying

    changsha cent hosp · univ south china

查看全部 3 位作者收起作者
  • D

    Deng, Jun-Li (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417